Rohit S Loomba1,2, Gaurav Aggarwal3, Saurabh Aggarwal4, Saul Flores5,6, Enrique G Villarreal7, Juan S Farias7, Carl J Lavie8. 1. Advocate Children's Hospital, Chicago, IL, USA. 2. Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL, USA. 3. Jersey City Medical Center, Jersey City, NJ, USA. 4. UnityPoint Health, Des Moines, IA, USA. 5. Texas Children's Hospital, Houston, TX, USA. 6. Baylor College of Medicine, Houston, TX, USA. 7. Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Monterrey, Mexico. 8. Ochsner Medical Center, New Orleans, LA, USA.
Abstract
OBJECTIVE: To utilize publicly reported, state-level data to identify factors associated with the frequency of cases, tests, and mortality in the USA. MATERIALS AND METHODS: Retrospective study using publicly reported data collected included the number of COVID-19 cases, tests and mortality from March 14th through April 30th. Publicly available state-level data was collected which included: demographics comorbidities, state characteristics and environmental factors. Univariate and multivariate regression analyses were performed to identify the significantly associated factors with percent mortality, case and testing frequency. All analyses were state-level analyses and not patient-level analyses. RESULTS: A total of 1,090,500 COVID-19 cases were reported during the study period. The calculated case and testing frequency were 3332 and 19,193 per 1,000,000 patients. There were 63,642 deaths during this period which resulted in a mortality of 5.8%. Factors including to but not limited to population density (beta coefficient 7.5, p < .01), transportation volume (beta coefficient 0.1, p < .01), tourism index (beta coefficient -0.1, p = .02) and older age (beta coefficient 0.2, p = .01) are associated with case frequency and percent mortality. CONCLUSIONS: There were wide variations in testing and case frequencies of COVID-19 among different states in the US. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality. Key messages There were wide variations in testing and case frequencies of COVID-19 among different states in the USA. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality.
OBJECTIVE: To utilize publicly reported, state-level data to identify factors associated with the frequency of cases, tests, and mortality in the USA. MATERIALS AND METHODS: Retrospective study using publicly reported data collected included the number of COVID-19 cases, tests and mortality from March 14th through April 30th. Publicly available state-level data was collected which included: demographics comorbidities, state characteristics and environmental factors. Univariate and multivariate regression analyses were performed to identify the significantly associated factors with percent mortality, case and testing frequency. All analyses were state-level analyses and not patient-level analyses. RESULTS: A total of 1,090,500 COVID-19 cases were reported during the study period. The calculated case and testing frequency were 3332 and 19,193 per 1,000,000 patients. There were 63,642 deaths during this period which resulted in a mortality of 5.8%. Factors including to but not limited to population density (beta coefficient 7.5, p < .01), transportation volume (beta coefficient 0.1, p < .01), tourism index (beta coefficient -0.1, p = .02) and older age (beta coefficient 0.2, p = .01) are associated with case frequency and percent mortality. CONCLUSIONS: There were wide variations in testing and case frequencies of COVID-19 among different states in the US. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality. Key messages There were wide variations in testing and case frequencies of COVID-19 among different states in the USA. States with higher population density had a higher case and testing rate. States with larger population of elderly and higher tourism had a higher mortality.
Authors: Saurabh Aggarwal; Nelson Garcia-Telles; Gaurav Aggarwal; Carl Lavie; Giuseppe Lippi; Brandon Michael Henry Journal: Diagnosis (Berl) Date: 2020-05-26
Authors: Ebony B Bookman; Kimberly McAllister; Elizabeth Gillanders; Kay Wanke; David Balshaw; Joni Rutter; Jill Reedy; Daniel Shaughnessy; Tanya Agurs-Collins; Dina Paltoo; Audie Atienza; Laura Bierut; Peter Kraft; M Daniele Fallin; Frederica Perera; Eric Turkheimer; Jason Boardman; Mary L Marazita; Stephen M Rappaport; Eric Boerwinkle; Stephen J Suomi; Neil E Caporaso; Irva Hertz-Picciotto; Kristen C Jacobson; William L Lowe; Lynn R Goldman; Priya Duggal; Megan R Gunnar; Teri A Manolio; Eric D Green; Deborah H Olster; Linda S Birnbaum Journal: Genet Epidemiol Date: 2011-05 Impact factor: 2.135
Authors: Fabrizio Carletti; Eleonora Lalle; Francesco Messina; Giuseppe Ippolito; Maria R Capobianchi Journal: J Med Virol Date: 2020-04-19 Impact factor: 2.327
Authors: Min W Fong; Huizhi Gao; Jessica Y Wong; Jingyi Xiao; Eunice Y C Shiu; Sukhyun Ryu; Benjamin J Cowling Journal: Emerg Infect Dis Date: 2020-05-17 Impact factor: 6.883
Authors: Niina Ikonen; Carita Savolainen-Kopra; Joanne E Enstone; Ilpo Kulmala; Pertti Pasanen; Anniina Salmela; Satu Salo; Jonathan S Nguyen-Van-Tam; Petri Ruutu Journal: BMC Infect Dis Date: 2018-08-29 Impact factor: 3.090
Authors: Marcos Felipe Falcão Sobral; Gisleia Benini Duarte; Ana Iza Gomes da Penha Sobral; Marcelo Luiz Monteiro Marinho; André de Souza Melo Journal: Sci Total Environ Date: 2020-04-26 Impact factor: 7.963
Authors: Søren Sperling; Andreas Fløe; Steffen Leth; Charlotte Hyldgaard; Tina Gissel; Ayfer Topcu; Lars Kristensen; Lene Dahl Sønderskov; Johannes Martin Schmid; Søren Jensen-Fangel; Elisabeth Bendstrup Journal: J Clin Med Date: 2022-04-25 Impact factor: 4.964